Post My Press Release

Free Press Release Distribution

Category: Healthcare (Page 1 of 169)

Teleradiology Market to Undertake Strapping Growth During 2018 to 2026

Teleradiology is a method used to transmit medical radiological images such as x-rays, CTs, and MRIs, from one location to another location. The purpose of this transmission of medical images is to enable easy viewing and interpretation for diagnostic or consultation by a radiologist. The process of teleradiology involves an image sending station, a receiving image station, and a transmission network that has high quality screen, which has been cleared for clinical purposes. Teleradiology is a means for collaboration of medical professionals, despite their location. Increasing demand for second opinion for medical treatments is expected to boost growth of the market for teleradiology.

Teleradiology is widely used in application such as telediagnosis, telemonitoring, picture archiving and communication system (PACS), and teleconsultation. This increases the efficiency of the radiologist carrying out the surgery. Ultrasound is one of the most promising imaging technology in teleradiology, which is widely being used for diagnosing medical aliments in women. Ultrasound helps in tracking and visualization of the development stages of fetus during pregnancy. This in turn increases growth of the teleradiology market.

Ask for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/549

Rising prevalence of chronic diseases to boost market growth

Rising prevalence of chronic disorders such as breast cancer, cellulitis, and osteomyelitis and the rising number of emergence cases in rural areas, which experiences the lack of skilled professional, are increasing demand for teleradiology services. Furthermore, rising expenditure on healthcare, improving healthcare infrastructure, and widening network of high-speed broadband services are expected to boost growth of the global market.

North America and Europe are expected to account for high market share, followed by Asia Pacific due to the rampant advancements in technology and high disposable income among the populace in the region. Increasing number of well-equipped healthcare centers and novel approaches to medicine are expected to fuel growth of the teleradiology market. Increasing incidence of chronic diseases such as cancer is creating a highly conducive environment for growth of the teleradiology market. For instance, according to the World Health Organization (WHO), in 2012, around 14 million cases of cancer were reported worldwide, leading to around 8.8 million deaths in 2015.

Key Players of Teleradiology Market:

Key players in the teleradiology market include Virtual Radiologic (vRAD), NightHawk Radiology, Inc., Sectra Imtec AB, StatRad, LLC, Agfa-Gevaert N.V., ONARD, Global Diagnostics, Everlight Radiology, 4ways Healthcare Limited, RamSoft, Inc., Sectra AB, Health Watch Tele Diagnostics Pvt. Ltd., Alta Vista Teleradiology, Argus Radiology, ONRAD, Inc., FujiFilm Medical Systems.

Teleradiology Market Taxonomy –

By Product:

  • Computed Tomography (CT)
  • X-ray
  • Ultrasound
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Imaging

By Application:

  • Tele-diagnosis
  • Tele-consultation
  • Tele-monitoring
  • Picture Archiving and Communication System (PACS)
  • Radiology Information System (RIS)

Browse Complete Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/teleradiology-market-549

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

2019 China Automated Microbiology Market: Supplier Shares, Regions, Volume and Sales Forecasts to 2023

Market Reports on China Provides the Trending Market Research Report on “2019-2023 China Automated Microbiology Market: Supplier Shares and Strategies, Volume and Sales Forecasts for 100 Molecular, Identification, Susceptibility, Blood Culture, Urine Screening and Immunodiagnostic Tests, Technologies, Instrumentation” under Diagnostics Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

This new report on automated microbiology market examines current and emerging assays; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay and application; profiles leading players and potential market entrants; and suggests alternative market penetration strategies for suppliers.

Request a free sample copy of Automated Microbiology Market Report @ http://www.marketreportsonchina.com/marketreports/Sample/Reports/1351005

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Market Segmentation Analysis

– Volume and sales forecasts for over 100 infectious disease assays by individual test.

– Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).

Specimen Types

– Urine
– Sterile Fluids: Blood, Serum, CSF
– Throat Swabs, Respiratory Secretions
– Genital Secretions
– Stool
– Abscess/Wound
– Sputum
– Saliva

Applications

– Microbial Identification
– Antibiotic Susceptibility
– Urine Screening
– Blood Cultures

Review of Major Automated Systems

– Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

– Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.

– Global listings of companies developing or marketing microbiology products by individual test.

Competitive Assessments

– Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategic Recommendations

– Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
– Design criteria for decentralized testing products.
– Alternative market penetration strategies.
– Potential market entry barriers and risks.


Browse our full report with Table of Contents: http://www.marketreportsonchina.com/marketreports/2019-2023-china-automated-microbiology-market-supplier-shares-and-strategies-volume-and-sales-forecasts-for-100-molecu/1351005

About Market Reports on China:
Market Reports on China is thus the one-stop solution for the entire market research requirements with regards to China.
We provide you with insight and analysis on the country’s economic outlook at the national, regional and city level, presenting deep understanding of disparities and evolutionary paths. Get a complete, consistent and concise view of your markets with comprehensive industry reports. Our latest regional databanks, forecasts, and detailed risk ratings will help you to identify risk and opportunities in every industry and develop strategic plans to deal with the competitiveness in the Chinese market.

Contact us:
Market Reports on China
Tel: +91 22 27810772 / 27810773
Email:info@marketreportsonchina.com
Website: http://www.marketreportsonchina.com

Follow us on: Twitter, Facebook, LinkedIn

Lung Cancer Therapeutics Market 2018: Future Demand, Market Analysis to 2026

Lung cancer is a malignant lung tumor, which is characterized by uncontrolled division and growth of cells in the lungs. The ability of lungs to provide oxygen into the bloodstream decreases with increasing size of tumor. The lung carcinoma is classified as, non-small cell and small cell lung cancer and originates from the epithelial cells. Lung cancer has the highest mortality rate globally, where exposure to asbestos, cigarette and pipe smoking is attributed the foremost reason. Major symptoms of lung cancer includes, body mucus, chest pain, weight loss, and coughing. Chemotherapy, immunotherapy, vaccines, and radiation therapy are the common lung cancer treatments.

Ask for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/702

Rising incidences of non-small cell lung cancer is expected to drive the global lung cancer therapeutics market

According to the World Health Organization estimates in 2017, 1.8 million new lung cancer cases were diagnosed in 2012 globally accounting for the leading causes of morbidity and mortality. The launch of innovative radiation therapies, premium priced drugs, and rising incidences of non-small cell lung cancer (NSCLC) are the major driving factors for the growth of the market. The rising demand for targeted therapies is likely to have an optimistic impact over the lung cancer therapeutics market in the forecast period. Targeted therapies block the growth by targeting cancer-specific proteins, cells, and tissues that lead to cancer survival and division, without damaging the healthy cells. They are also proved to have higher efficiency over conventional therapies like platinum-based chemotherapy, surgical resection, and radiation therapy.

Higher carcinoma lung population dominates the lung cancer therapeutics market in North America

Regional segmentation of the lung cancer therapeutics market by Coherent Market Insights comprises North America, Europe, Asia-Pacific, Latin America and Middle East, and Africa. According to the American Cancer Society estimates of 2017, approximately 195,000 people are suffering from NSCLC every year in the U.S. where, the number of deaths from NSCLC is recorded to be around 135,000, thus increasing the demand for lung cancer therapeutics in North America.

New product launches with higher efficiency forms a major growth strategy of market players

The key players operating the lung cancer therapeutics market are Pfizer, Celgene, F. Hofmann-La Roche, AstraZeneca and Eli Lilly. The key players adopt various strategies such as, development of efficient drugs, acquisition and mergers, geographical expansion and major investment in research and development to maintain their position in the market. Other prominent vendors include ARIAD Pharmaceuticals, OSE Immunotherapeutics, Novartis, Bristol-Myers Squibb, OncoGeneX.

Lung Cancer Therapeutics Market Taxonomy –

The global lung cancer therapeutics market is segmented on the basis of therapy, distribution channel, and geography

On the basis of therapy, the global lung cancer therapeutics market is segmented into:

  • Chemotherapy
  • Gemzar
  • Alimta
  • Paraplatin
  • Taxotere
  • Navelbine
  • Targeted therapy
  • Avastin
  • Tarceva
  • Iressa
  • Gilotrif
  • Radiotherapy
  • Systemic Radiotherapy
  • External Beam Radiotherapy
  • Internal Radiotherapy

For More Information, Browse Full Report Here: https://www.coherentmarketinsights.com/ongoing-insight/lung-cancer-therapeutics-market-702

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Patient Handling Equipment Market Upcoming Trends, Demand and Analysis Till 2026

Patient handling equipment is an assistive devices allowing the hospitalized patients to transfer to other places who lack the strength to control the body movements. Patient handling equipment’s are specially designed in helping the patients in hospitals, nursing homes and medical centers with some mobility. The equipment’s are cost efficient than retrofitting, assures increased productivity of care givers and ensures patient’s safety. The manual patient handling devices are based on mechanical assessment of patients to ensure safety to the patient, caregiver and rehabilitation goals.

Increasing disabilities post surgeries is expected to drive the patient handling equipment market

According to the World Health Organization, in 2017, an estimated 1.8 million patients suffered from some form of disability in 2015 and then approximately globally each year, the number of disabilities being expected to increase to 2.43 million patients by 2030. The increasing demand for advanced technological products in medical field, increasing need of equipment’s to handle patients post critical surgeries like orthopedic, cardiac and bariatric surgeries propels patient handling equipment’s market over the forecast period. The increasing prevalence of disabilities after serious accidents and surgeries, increase in the geriatric population is anticipated to drive the patient handling equipment market. The introduction of technologically advanced efficient products which offer easy usage and prevents musculoskeletal disorders in caregivers are expected to drive growth in the near future.

Request For Sample Copy of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/700

Medical beds segment is expected to account for the largest share of the patient handling equipment market

The global patient handling equipment market is segmented on the basis of product type, accessories, end user and geography.

On the basis of product type:

Increasing number of musculoskeletal disorders is expected to accelerate the demand of patient handling equipment market in North America

Regional segmentation of the global patient handling equipment market by Coherent Market Insights comprises North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. According to the U.S. Bone and Joint Initiative, in 2014, an estimated 4.5 million sports were related to musculoskeletal injuries recorded in the U.S., with millions suffering from spine deformities, cancers of bones and connective tissues and congenital conditions, thus adding up to the market growth. North America is expected to grow at a lucrative rate owing to supportive government assistance for improvisation in infrastructure and medical facilities and rising demand for home care equipment.

The launch of specialist pediatric bed is expected to boost the sales of patient handling equipment market

Key players operating the patient handling equipment market include Stryker Corporation, Bayer AG, Hill-Rom Holdings Inc, Invacare Corporation. Other prominent vendors incorporated the strategies of mergers, acquisition for patient handling and care include Etac Ltd, Guldmann Inc, Prism Medical Ltd, Stiegelmeyer Inc, Benmor Medical Ltd, Linet Americas Inc and ArjoHuntleigh Inc. The launch of new specialist pediatric bed by Sidhil Ltd. in 2016 as an extension to the products proved beneficial to improve its sales.

Click to read more on Patient Handling Equipment Market

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Flexible Plastic Packaging Market is expected to grow up to 131.65 Billion USD By 2022

The report [215 pages] “Flexible Plastic Packaging Market by Type (Stand-Up Pouches, Flat Pouches, Gusseted Bags, Wicketed Bags, Wraps, Rollstock), Material (Plastic Films, Paper, Aluminum Foil, Bioplastics), Printing Technology, Application, and Region – Global Forecast to 2022″, published by MarketsandMarkets™, the market is projected to grow from USD 102.19 Billion in 2017 to reach USD 131.65 Billion by 2022, at a CAGR of 5.2%.

Request for free PDF sample report:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1271 

Table of Contents

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights 

5 Market Overview

6 Industry Trends

7 Macro Economic Overview

8 Flexible Plastic Packaging Market, By Type

9 Flexible Plastic Packaging Market, By Material

10 Flexible Plastic Packaging Market, By Printing Technology

11 Flexible Plastic Packaging Market, By Application

12 Flexible Plastic Packaging Market, By Region

13 Competitive Landscape

14 Company Profiles

15 Appendix

In 2016, the Asia-Pacific region accounted for the largest share in the total market for flexible plastic packaging, in terms of value, followed by North America and Europe, owing to manufacturers’ focus on developing low-cost flexible plastic packaging options. The Asia-Pacific region is projected to register the highest growth during the forecast period; this is attributed to the large customer base for FMCG products and consumer durables, due to the growth in population in countries of this region; this, in turn, is expected to lead to the growth of the flexible plastic packaging market. The flexible plastic packaging market in the North American region is developed and matured; the markets in the U.S. and Canada are projected to grow the highest rates from 2016 to 2022.

The market ecosystem involves various stakeholders in the flexible plastic packaging market. It starts with the raw material suppliers such as Amcor Limited (Australia), Bemis Company, Inc. (U.S.), Constantia Flexibles Group GmbH (Austria), Sealed Air Corporation (U.S.), and Huhtamäki Oyj (Finland), that are the manufacturing companies of the flexible plastic packaging. The next level in the chain involves the assembly team that is monitored by the manufacturers such as Coveris Holdings S.A. (U.S.), Sonoco Products Company (U.S.), Berry Plastics Group, Inc. (U.S.), Mondi Group (Austria), Reynolds Group Holdings (New Zealand), and Reynolds Group Holdings (Netherlands). It is followed by the marketing and sales of the finished products, which is only possible if an efficient distribution channel is developed. Finally, the end products are distributed to the consumers.

Early buyers will receive 10% customization on this report.

Don’t miss out on business opportunities in Flexible Plastic Packaging Market.

Read our blog for more details: https://chemabd007.blogspot.com/2019/05/flexible-plastic-packaging-market-with.html

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA: 1-888-600-6441 
sales@marketsandmarkets.com

Vertebral Compression Fracture Devices Market Prophesied to Grow at a Faster Pace by 2026

The micro-breaks in the building blocks of vertebra mainly caused by bone-thinning are termed as vertebral compression fractures (VCFs). Vertebral compression fracture occurs due to compression of a single bone due to trauma. The surgical approach for VCF treatment comprises injecting bone cement through a small hole in the fractured vertebra to provide immediate pain relief and stabilization to the patient. The cementing material provides a scaffold for the spine bone for added support. Thinning of corticles, reduction in bone mineral density, and osteoporosis are the major factors causing vertebral compression fractures. Postmenopausal women are more prone to vertebral fractures. The ultimate goal of the vertebral compression fracture devices is to eliminate back pain, fuse and repair fractures, restore posture, and provide ease of movement.

Ask for Sample Copy of Research Report At https://www.coherentmarketinsights.com/insight/request-sample/802

Rising prevalence of osteoporosis drives the vertebral compression fracture devices market

According to the International Osteoporosis Foundation estimates in 2010, osteoporosis affects 200 million people globally with approximate 9 million new osteoporotic fractures, with 1.6 million hip fractures, 1.7 million forearm fractures, and 1.4 million clinical vertebral fractures. The rising incidence of arthritis and osteoporosis, inability of medicinal therapy to cure vertebral compression fracture to the optimum level, and the advent of minimally invasive spine surgeries drives the growth of vertebral compression fracture devices market. Moreover, short recovery period, low risk of infection, limited hospital stay, and rise in geriatric population are projected to boost the demand for VCF devices globally. However, stringent regulatory approval process and the risk of post-surgical complications such as neurological injury and compromised pulmonary function are expected to restrain the market growth.

Asia Pacific is projected to grow rapidly with the rise in healthcare expenditures to cater the unmet medical needs

Regional segmentation of the global VCF market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. According to the World Health Organization estimates in 2015, vertebral compression fractures (VCF) are the common type of fragility fractures with 700,000 VCF cases per year in the U.S., with 30% postmenopausal women likely to experience humerus, hip, and spine fractures, thereby propelling the demand for innovative VCF devices. North America is expected to dominate the global market, owing to the surge in procedure volumes, rising prevalence of impairments, spinal disorders such as spinal stenosis, well-defined reimbursement policies, supportive economic base, and high awareness of VCF conditions and treatments available.

Delivering high quality minimally invasive products is expected to push the manufacturing envelope

Key players operating in the global vertebral compression fracture devices market include Alphatec Holdings, Inc., Depuy Synthes, Osseon LLC, VEXIM SA, and Orthovita, Inc. The launch of innovative CurvePlus device and InterV line offers atraumatic treatment allowing pain management clinics to have a safer and quicker procedure. Other key vendors include Stryker Corporation, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., DFine, Inc. and CareFusion Corporation.

Balloon kyphoplasty devices segment is expected to procure largest revenue owing to its beneficial effects

The global vertebral compression fracture devices market is segmented on the basis of technology, diagnosis, surgery, end user, and geography.

On the basis of technology, the global vertebral compression fracture devices market is segmented into:

  • Balloon Kyphoplasty Devices
  • Vertebroplasty Devices

On the basis of diagnosis, the global vertebral compression fracture devices market is segmented into:

  • X-rays, CT scan or MRI
  • Radio Scan

On the basis of surgery, the global vertebral compression fracture devices market is segmented into:

  • Open Spine Surgery
  • Minimally Invasive Spine Surgery
  • Lumbar Fusion

Browse Complete Research Report At https://www.coherentmarketinsights.com/ongoing-insight/vertebral-compression-fracture-devices-market-802

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Virginiamycin Market Moving Toward 2026 With New Procedures

Virginiamycin is an antibiotic produced by Streptomyces virginiae and belongs to the streptogramin group, which has two synergistic factors: M (hybrid polyketide-peptide) and S (peptide). It is used in the fuel ethanol industry to prevent microbial contamination. Virginiamycin is an antibiotic, which was marketed for vancomycin resistant enterococcus in the U.S. in 1999. It is also used in the agriculture sector specifically in livestock to accelerate the growth of animals and prevent and treat infections. Virginiamycin is a mixture of two principle components of virginiamycin M1 and virginiamycin S1. Virginiamycin controls microbial growth within lumen of gastrointestinal tract by disrupting bacterial protein synthesis. Click To Read More On Virginiamycin Market.

Virginiamycin can also be used as a growth stimulator as it optimizes the absorption and metabolism of nutrients. It also improves the state of small intestine epithelium and inhibits the growth of harmful toxins and metabolites by gut organisms. Virginiamycin is used for the treatment of necrotic enteritis in broiler chickens — a common fatal gastrointestinal disease in poultry.

Virginiamycin Market- Dynamics

Pharmaceutical manufacturers are focused launching new products to address limited availability of Virginiamycin and to enhance their market share. This in turn is expected to augment the market growth. For instance, in January 2019, Phibro Animal Health Corp. announced that its virginiamycin medicated feed additive received regulatory approval by Veterinary Drugs Directorate (VDD), Health Canada, for use in beef cattle. According to Phibro Animal Health Corp., V-max (virginiamycin) is approved for the reduction of incidence of liver abscesses in cattle fed in confinement.

In developing countries there is rapid increase of demand for livestock. In developed countries, demand for livestock is stagnating. Increasing demand for livestock due to growing human population is expected to boost growth of the market. Increasing livestock production leads to high demand for animal feed.

Stringent regulations by the regulatory agencies is expected to hinder market growth. In September 2015, the European Commission adopted the regulation establishing maximum residue limits for virginiamycin in poultry species, which is valid throughout the European Union.

Virginiamycin Market- Competitive Analysis

Key players in the market are focused on development, manufacturing, and marketing of multisource and branded pharmaceuticals, thereby augmenting the market growth. For instance, in January 2017, Huvepharma AD received approval for STAFAC (virginiamycin) plus CLINACOX (diclazuril) combination drug type in chickens for prevention of necrotic enteritis and coccidiosis in broiler chickens.

Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/2621

Key players operating in the global virginiamycin market include, Hongcong Xinrunde Chemical Co., Ltd, Xiamen ShengLang SaiChuang Biological Technology Co., Ltd., Manus Aktteva Biopharma, Alfanzyme, Phibro Animal Health Corporation, Merck Animal Health, Zoetis, Elanco, Virbac, Ceva, and Vetoquinol.

Virginiamycin Market- Regional Dynamics

On the basis of region, the global virginiamycin market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The rapid increase in livestock animals is the main reason for North America region to hold a dominant position in the global virginiamycin market over the forecast period in terms of revenue share followed by Europe. The virginiamycin market in this region has been growing due to the necessity for the additional supplements in the diet for a companion as well as livestock animals for appropriate nutrition. The consumption of virginiamycin is high in Europe, which is expected to drive the virginiamycin market growth in the region. For instance, in January 2017, virginiamycin was approved for use in feed. Upon completion of voluntary conversion from over the counter to veterinary feed directive(VFD), all feed uses of the virginiamycin alone or in a combination, will require the VFD. The proprietary drug names of virginiamycin is Stafac and V-max.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Global Ayurvedic Products Market Demand, Scope, Future Expectations, Market overview by 2025

Market Research Hub (MRH) has actively included a new research study titled “Global Ayurvedic Products Market Size, Status and Forecast 2019-2025” Insights, Forecast to 2025 to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until forecast period limit; 2025. In addition, a deep analysis of the competitive landscape, including prime market players is also enclosed in this report.

Get an Exclusive Sample of this Report@ – https://www.marketresearchhub.com/enquiry.php?type=S&repid=2342825

Ayurveda is an ancient system of life and also the oldest surviving medical system in the world. Ayurvedic science is not merely a traditional Indian form of medicine but a perennial naturopathic system of healthcare that has survived the test of time as well as onslaught of modern science and methods of treatments.
Ayurveda is an ancient system of life and also the oldest surviving medical system in the world. Ayurvedic science is not merely a traditional Indian form of medicine but a perennial naturopathic system of healthcare that has survived the test of time as well as onslaught of modern science and methods of treatments.

Although the market competition of ayurvedic is fierce globally, there are many enterprises can obtain considerable profit form the manufacturing and marketing of ayurvedic and that is the reason that we believe there will also be enterprises enter this market. But it is suggested that enterprises those have plans to enter this industry have careful analysis of this market and the advantages or disadvantages of themselves.
In 2018, the global Ayurvedic Products market size was 5170 million US$ and it is expected to reach 11400 million US$ by the end of 2025, with a CAGR of 12.0% during 2019-2025.

This report focuses on the global Ayurvedic Products status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ayurvedic Products development in United States, Europe and China.

The key players covered in this study
Patanjali Ayurved Limited
Dabur
Emami Group
Himalaya Drug
Maharishi Ayurveda
Baidyanalh
Shahnaz Husain Group
Vicco Laboratories
Amrutanjan Healthcare
Charak Pharma
Botique
Herbal Hills
Basic Ayurveda
Natreon

Market segment by Type, the product can be split into
Health Care
Oral Care
Hair Care
Skin Care
Others

Market segment by Application, split into
Women
Men
Kids

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

In this study, the years considered to estimate the market size of Ayurvedic Products are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Detailed Analysis of this Research Report@ – https://www.marketresearchhub.com/report/global-ayurvedic-products-market-size-status-and-forecast-2019-2025-report.html

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ayurvedic Products Market Size Growth Rate by Type (2014-2025)
1.4.2 Health Care
1.4.3 Oral Care
1.4.4 Hair Care
1.4.5 Skin Care
1.4.6 Others
1.5 Market by Application
1.5.1 Global Ayurvedic Products Market Share by Application (2014-2025)
1.5.2 Women
1.5.3 Men
1.5.4 Kids
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Ayurvedic Products Market Size
2.2 Ayurvedic Products Growth Trends by Regions
2.2.1 Ayurvedic Products Market Size by Regions (2014-2025)
2.2.2 Ayurvedic Products Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Ayurvedic Products Market Size by Manufacturers
3.1.1 Global Ayurvedic Products Revenue by Manufacturers (2014-2019)
3.1.2 Global Ayurvedic Products Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Ayurvedic Products Market Concentration Ratio (CR5 and HHI)
3.2 Ayurvedic Products Key Players Head office and Area Served
3.3 Key Players Ayurvedic Products Product/Solution/Service
3.4 Date of Enter into Ayurvedic Products Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Ayurvedic Products Market Size by Type (2014-2019)
4.2 Global Ayurvedic Products Market Size by Application (2014-2019)

5 United States
5.1 United States Ayurvedic Products Market Size (2014-2019)
5.2 Ayurvedic Products Key Players in United States
5.3 United States Ayurvedic Products Market Size by Type
5.4 United States Ayurvedic Products Market Size by Application

TOC continued…!

Enquire before purchase@ – https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2342825

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like healthcare market research  and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us         

90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)

Email: press@marketresearchhub.com

Website: http://www.marketresearchhub.com/

Read Industry News at: https://www.industrynewsanalysis.com/

Page 1 of 169

Powered by WordPress & Theme by Anders Norén